SVG103: clinical trials recruiting now

Fewer than 3 recruiting trials found.

1

Recruiting trials

4

Conditions studied

0

US states with sites

1

Countries

Phase breakdown

Phase 1 1 Phase 2 1

Conditions being studied

Condition	Trials
Focal Cortical Dysplasia	1
Hemimegalencephaly	1
Multiple sclerosis	1
Tuberous Sclerosis Complex (TSC)	1

Recruiting trials involving SVG103

Safety, Tolerability, and Pharmacokinetics of SVG103 (Paxalisib) in Focal Cortical Dysplasia Type II (FCD-II), Tuberous Sclerosis Complex (TSC) or Hemimegalencephaly (HME)
NCT07287202 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 2 locations

Common questions

How many recruiting trials involve SVG103?

1 recruiting trial across 4 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.